_id
690da963ccc777a4e85d0847
Ticker
ACUT
Name
Accustem Sciences Inc
Exchange
OTCQB
Address
5 Penn Plaza, New York, NY, United States, 10001
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://accustem.com
Description
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-invasive blood testing technologies. AccuStem Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.
Last Close
0.68
Volume
800
Current Price
0.62
Change
-0.0999
Last Updated
2026-01-21T20:52:34.271Z
Image
data:image/webp;base64,UklGRngGAABXRUJQVlA4WAoAAAAQAAAAPwAAPwAAQUxQSDgEAAABoEVr2zE3u5/3i2rbtm3btm3btm3bthubtW130GTuH98kk2/OehQRE4C/nsXJXBScWJDF95lPIafKFv6en1+0h3IS3eWPX/eCi7OkyZsnZ+GqZdzgnApzyN+mn19/ReRL5AzKFUN9wqgb/ak2lOF00589u3vv9k37LxSAqzKYe+Vu45ds2Hvm1NHD65dP7t80K4yt0IZxjexU3GC5Z0yIIRlt+vrty8cff0gyK8QoAt1+i7vXKpE/Tco0WQsUq9hk5FCBMgrcc9QcsPTQ0dt73dwB7H93Zc+iAVWzJgcgBhCkXhH8Noa6T983RaJtj/h/U/ih0jCiQnnqmz88f+xZDAAa3Ih8ZyYZE9UBEm+iqcLJ1v4M2r93z8ZVs+cuXzFlUv+WNUsXK9Ow/yofro43JQBS1llQD1m/0Eb7MR+CjkxvmTdxOkCT+AFyj77wllw0aMSSRS//F22z0e7vgIVVNAAqHqTlGQv1zwANFwzu3KhS5UrlarfoOW2b57NokuFTC8HxglQ/+Z3kl4B9C3p3m75o3Z69Bw4d3rFsbPvy2d3gUbjXtkjSdLiRwwCpW3AJI/Zt3u/9+Dvj+OPB4REFAVVmzgP+TAVxkAag0mnPZzbatXx8/vjuvWfvv1M3ckF5AC3bwsEa4Nr0wKto0kZan9zaN3dot9Zt6hTNlzN//mINR27z/EgyYEgWQIkjFODaN4BkDMl7a1Zu2HP8VlDovRdP7kX5Hl89vEZKIGWd2WGkeQ4ApeIiCmgWSlqiyVfbGqMd4266PbmiBlRc8Xaba6OsgEisBCh1nLY33yy8OzgdgHKblv2h9bX/maNHNqw/eOJG+EeSvLukEpAI1floRm1Ai4VAJpkYEfWLNj7P5ppMKQAtB9WpWr5CUuinKdtnXTjJW8PSwH0BadqYHvYF6a/z4/kHJGnjDesWIE2VIUsuvrTaeBJKwWP4hOqpABSe5kd+nJ4JxT3JDy3tKZQ3n9jyizZav1jJ18u6H/1A8ue92+eO9gUUMr4lLdcmlgHQ6Aj5YWFqjDlvZRUoHUDyYiLJ58/MtqfXvD+T9zd2L5MlmcBurjaL/Uj6jEgN1LhIvh4N1J6bAWJHIek+fvV6RPOjp+TjhSUV9EV0/p9jtC/5eVpqoO9r8nYhxFZQ8R6DLn2i+Qt5omlCAEopEdgXpQCg4rqvfD0sIXIeJL8MFig76GTlwWuklTxcGYCm4EjRAORbZKZvLWDYL3JXImh6A/lruR9jyND6ABQcrwTIc4Sc54Lar0jPdFCAYATfTIughZZZ7hCF+BUFdH3DC7lQNJyMKgKBYMHd7ndo5qPagIb4V0DOU3xSDVn8yReFIYDmltyfvJoeSmBIDbKU3xsiS6N57AQFAO6B3O0ODUZVwGiyFoBiHgAgcFu32gUajCvAQPaHO2IvMLIAqTUAKhYCowucXpzuL2JWUDggGgIAAPALAJ0BKkAAQAA+tVCgTCckoyIqFmug4BaJYgDPfaawtv0AbwBvK6/yWgyyNJAz6rThfYpQJYoAELSogQphtx1l+tsN0wwQD4Jp2XzxIDK4Ej3n82Q+3JifrixfYp2ROp42+t1HL5cwAP78XNkPwVL6NnPYz/pxfKHGhvZbjtvtggFsatTQbg9fvW4pnLaql9nIILuAi6RVxxff4Z9XKMnCFMdFF1Jr9GJXoDBSOlz+IfIfxLe4rc3E+XBHEkzGKGQ/xVuiMbv7lAGCWh1Hhgg5cRPNlTIt0qkOzuMSDJtT2CjZAg9ySPYdSYcgPj05PhkLk/GNi7WDd66bs2v6IQcD53KD8j3d/uICVDo4j1oHka6i3BDsFQXxKInDBKYlnViMZ6ev4B1FPWVV3TlLgAZo+tSHJ646E+Bo6eyprEdJgxUWnh2Hyp4u94ikiM+GhPNTKFtb5XfVd7lI5UHVPEgm6CcleVinh7p2NoZBe6FQqA4k3QExjSFDETGeb4mSYuFL4RW7U31w2hvKmmIS6EiREdNJ0GcpRzYYtMaMboOZr7h+ISDnheDh8+9dfrTDAM3SXB1L1YZkVzDNveQTNXGfmC5FfIWwnnhtZgYBzEBqUwR22Aa1x7FX/4PB6C7YOZt7tDM/Gu/vNc7iTFHY2b3PyRdeZjf8Vrf/95HNjvFjmv8B0l7DY3yUVJAQjpQB02heI8Eca3EJAAA=
Ipo Date
-
Market Cap
9964806
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
399897
Operating Income
-399897
Interest Expense
-
Pretax Income
-399897
Net Income
-399897
Eps
-0.02488118197638205
Dividends Per Share
-
Shares Outstanding
16072267
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
14391
Short Term Investments
-
Receivables
-
Inventories
-
Total Current Assets
1573247
Property Plant Equipment
0
Total Assets
1573247
Payables
923191
Short Term Debt
-
Long Term Debt
-
Total Liabilities
4484157
Equity
-2910910
Bs_currency_symbol
USD
Depreciation
0
Change In Working Capital
-227908
Cash From Operations
-604131
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
587181
Net Change In Cash
-16950
Cf_currency_symbol
USD
PE
-
PB
-3.42326129629566
ROE
13.737868913844812
ROA
-25.418576993949454
FCF
-604131
Fcf Percent
-
Piotroski FScore
1
Health Score
26
Deep Value Investing Score
1
Defensive Investing Score
6.5
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
1
Growth Investing Score
0.5
Momentum Investing Score
2.5
Net Net Investing Score
0.5
Quality Investing Score
1.5
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
399897
Quarters > 0 > income Statement > operating Income
-399897
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-399897
Quarters > 0 > income Statement > net Income
-399897
Quarters > 0 > income Statement > eps
-0.02488118197638205
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
16072267
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
14391
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
-
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1573247
Quarters > 0 > balance Sheet > property Plant Equipment
0
Quarters > 0 > balance Sheet > total Assets
1573247
Quarters > 0 > balance Sheet > payables
923191
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
4484157
Quarters > 0 > balance Sheet > equity
-2910910
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-399897
Quarters > 0 > cash Flow > depreciation
0
Quarters > 0 > cash Flow > change In Working Capital
-227908
Quarters > 0 > cash Flow > cash From Operations
-604131
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
587181
Quarters > 0 > cash Flow > net Change In Cash
-16950
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.02488118197638205
Quarters > 0 > ratios > PB
-3.42326129629566
Quarters > 0 > ratios > ROE
13.737868913844812
Quarters > 0 > ratios > ROA
-25.418576993949454
Quarters > 0 > ratios > FCF
-604131
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
26
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
401403
Quarters > 1 > income Statement > operating Income
-401403
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-401403
Quarters > 1 > income Statement > net Income
-401403
Quarters > 1 > income Statement > eps
-0.024974883754731052
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
16072267
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
31341
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
-
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1613537
Quarters > 1 > balance Sheet > property Plant Equipment
0
Quarters > 1 > balance Sheet > total Assets
1613537
Quarters > 1 > balance Sheet > payables
859925
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
4148224
Quarters > 1 > balance Sheet > equity
-2534687
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-401403
Quarters > 1 > cash Flow > depreciation
105
Quarters > 1 > cash Flow > change In Working Capital
399624
Quarters > 1 > cash Flow > cash From Operations
21567
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-26607
Quarters > 1 > cash Flow > net Change In Cash
-5040
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.024974883754731052
Quarters > 1 > ratios > PB
-3.93137517176677
Quarters > 1 > ratios > ROE
15.836393211469503
Quarters > 1 > ratios > ROA
-24.877210748808363
Quarters > 1 > ratios > FCF
21567
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
47
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
440408
Quarters > 2 > income Statement > operating Income
-440408
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-440408
Quarters > 2 > income Statement > net Income
-440408
Quarters > 2 > income Statement > eps
-0.027401734926379706
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
16072267
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
36381
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
1550479
Quarters > 2 > balance Sheet > property Plant Equipment
105
Quarters > 2 > balance Sheet > total Assets
1550584
Quarters > 2 > balance Sheet > payables
849071
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3707108
Quarters > 2 > balance Sheet > equity
-2156524
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-440408
Quarters > 2 > cash Flow > depreciation
313
Quarters > 2 > cash Flow > change In Working Capital
52806
Quarters > 2 > cash Flow > cash From Operations
-290182
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
321517
Quarters > 2 > cash Flow > net Change In Cash
31335
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.027401734926379706
Quarters > 2 > ratios > PB
-4.620771918142344
Quarters > 2 > ratios > ROE
20.422123750999294
Quarters > 2 > ratios > ROA
-28.40271794369089
Quarters > 2 > ratios > FCF
-290182
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
372101
Quarters > 3 > income Statement > operating Income
-372101
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-372101
Quarters > 3 > income Statement > net Income
-372101
Quarters > 3 > income Statement > eps
-0.030750789118001807
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
12100535
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
5046
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
50433
Quarters > 3 > balance Sheet > property Plant Equipment
418
Quarters > 3 > balance Sheet > total Assets
50851
Quarters > 3 > balance Sheet > payables
804615
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3364075
Quarters > 3 > balance Sheet > equity
-3313224
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-372101
Quarters > 3 > cash Flow > depreciation
907
Quarters > 3 > cash Flow > change In Working Capital
119097
Quarters > 3 > cash Flow > cash From Operations
414
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-32447
Quarters > 3 > cash Flow > net Change In Cash
-32033
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.030750789118001807
Quarters > 3 > ratios > PB
-2.2643599406499533
Quarters > 3 > ratios > ROE
11.230783068093192
Quarters > 3 > ratios > ROA
-731.7476549133744
Quarters > 3 > ratios > FCF
414
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
43
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
1505102
Annuals > 0 > income Statement > operating Income
-1505102
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-1505102
Annuals > 0 > income Statement > net Income
-1505102
Annuals > 0 > income Statement > eps
-0.12438309545817602
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
12100535
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
5046
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
-
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
50433
Annuals > 0 > balance Sheet > property Plant Equipment
418
Annuals > 0 > balance Sheet > total Assets
50851
Annuals > 0 > balance Sheet > payables
804615
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3364075
Annuals > 0 > balance Sheet > equity
-3313224
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-1505102
Annuals > 0 > cash Flow > depreciation
3630
Annuals > 0 > cash Flow > change In Working Capital
533948
Annuals > 0 > cash Flow > cash From Operations
-664066
Annuals > 0 > cash Flow > capital Expenditures
0
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
647632
Annuals > 0 > cash Flow > net Change In Cash
-16434
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-0.12438309545817602
Annuals > 0 > ratios > PB
-2.2643599406499533
Annuals > 0 > ratios > ROE
45.42711268540853
Annuals > 0 > ratios > ROA
-2959.827732001337
Annuals > 0 > ratios > FCF
-664066
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
31
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
2050664
Annuals > 1 > income Statement > operating Income
-2050664
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-2050664
Annuals > 1 > income Statement > net Income
-2050664
Annuals > 1 > income Statement > eps
-0.18073041681887908
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
11346535
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
21481
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
-
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
129849
Annuals > 1 > balance Sheet > property Plant Equipment
4048
Annuals > 1 > balance Sheet > total Assets
133897
Annuals > 1 > balance Sheet > payables
578378
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
2245477
Annuals > 1 > balance Sheet > equity
-2111580
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-2050664
Annuals > 1 > cash Flow > depreciation
3630
Annuals > 1 > cash Flow > change In Working Capital
352757
Annuals > 1 > cash Flow > cash From Operations
-1615643
Annuals > 1 > cash Flow > capital Expenditures
0
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
903146
Annuals > 1 > cash Flow > net Change In Cash
-712497
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.18073041681887908
Annuals > 1 > ratios > PB
-3.3315582170696825
Annuals > 1 > ratios > ROE
97.11514600441376
Annuals > 1 > ratios > ROA
-1531.5234844694055
Annuals > 1 > ratios > FCF
-1615643
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
30
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
3746419
Annuals > 2 > income Statement > operating Income
-3746419
Annuals > 2 > income Statement > interest Expense
-
Annuals > 2 > income Statement > pretax Income
-3746419
Annuals > 2 > income Statement > net Income
-3746419
Annuals > 2 > income Statement > eps
-0.33018176914802627
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11346535
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
733978
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
-
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
932011
Annuals > 2 > balance Sheet > property Plant Equipment
7678
Annuals > 2 > balance Sheet > total Assets
939689
Annuals > 2 > balance Sheet > payables
311834
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
1079239
Annuals > 2 > balance Sheet > equity
-139550
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-3746419
Annuals > 2 > cash Flow > depreciation
3321
Annuals > 2 > cash Flow > change In Working Capital
1870137
Annuals > 2 > cash Flow > cash From Operations
-1806053
Annuals > 2 > cash Flow > capital Expenditures
10999
Annuals > 2 > cash Flow > cash From Investing
-10999
Annuals > 2 > cash Flow > cash From Financing
2551030
Annuals > 2 > cash Flow > net Change In Cash
733978
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-0.33018176914802627
Annuals > 2 > ratios > PB
-50.41097599426729
Annuals > 2 > ratios > ROE
2684.64278036546
Annuals > 2 > ratios > ROA
-398.6871188233554
Annuals > 2 > ratios > FCF
-1817052
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
30
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
-
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
1353373
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1353373
Annuals > 3 > balance Sheet > property Plant Equipment
-
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
388681
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
702700
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-670614
Annuals > 3 > cash Flow > depreciation
3321
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
-1806053
Annuals > 3 > cash Flow > capital Expenditures
10999
Annuals > 3 > cash Flow > cash From Investing
-10999
Annuals > 3 > cash Flow > cash From Financing
2551030
Annuals > 3 > cash Flow > net Change In Cash
733978
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
-1817052
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
45
Valuation > metrics > PE
-0.02488118197638205
Valuation > metrics > PB
-3.42326129629566
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
13.737868913844812
Profitability > metrics > ROA
-25.418576993949454
Profitability > metrics > Net Margin
-
Profitability > final Score
27
Profitability > verdict
Weak
Risk > metrics > Debt Equity
-
Risk > metrics > Interest Coverage
-
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.704140313326278
Liquidity > metrics > Quick Ratio
1.704140313326278
Liquidity > final Score
93
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
32
Prev Profitabilities > 1
40
Prev Profitabilities > 2
22
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
97
Prev Liquidities > 1
96
Prev Liquidities > 2
13
Updated At
2026-01-21T20:52:34.998Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.0249
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.025
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.0346
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.0318
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-09-30
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.0289
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-09-16
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.0245
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-20
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.0464
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.0217
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.0528
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.0329
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.0734
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.0862
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-09-30
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
-
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.0793
Earnings History > 12 > eps Estimate
-
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-06-30
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
-
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.0951
Earnings History > 13 > eps Estimate
-
Earnings History > 13 > eps Difference
0
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-03-31
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
-
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.0788
Earnings History > 14 > eps Estimate
-
Earnings History > 14 > eps Difference
0
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2021-09-30
Earnings History > 15 > report Date
2021-09-30
Earnings History > 15 > date
2021-09-30
Earnings History > 15 > before After Market
-
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.0055
Earnings History > 15 > eps Estimate
-
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2021-06-30
Earnings History > 16 > report Date
2021-06-30
Earnings History > 16 > date
2021-06-30
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.0045
Earnings History > 16 > eps Estimate
-
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2021-03-31
Earnings History > 17 > report Date
2021-03-31
Earnings History > 17 > date
2021-03-31
Earnings History > 17 > before After Market
-
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.0014
Earnings History > 17 > eps Estimate
-
Earnings History > 17 > eps Difference
0
Earnings History > 17 > surprise Percent
-
AccuStem Sciences, Inc., a clinical stage diagnostics company, focuses on developing and commercializing a suite of novel genomic tests for oncology care. It offers MSC test, a 24-micro RNA (miRNA) assay designed to help determine whether lung nodules identified by low dose computer tomography screening are benign or malignant. The company also provides StemPrintER, a 20-gene prognostic assay to predict the risk of distant recurrence in luminal breast cancer patients. The company has a partnership with EmeritusDX for the development of non-invasive blood testing technologies. AccuStem Sciences, Inc. was founded in 2013 and is headquartered in New York, New York.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AMidcap stock falls 5% following weak Q3 results and a cut in FY26 growth guidance - Trade Brains
1/16/2026
Midcap stock falls 5% following weak Q3 results and a cut in FY26 growth guidance Trade Brains
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Medium
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Accustem Sciences Inc
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.0249
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.